Petah Tiqva, HaMerkaz, Israel In 1901 was created Teva Pharmaceutical Industries, which is appeared as Corporate Investor. The venture was found in Asia in Israel. The leading representative office of defined Corporate Investor is situated in the Petah Tiqva.
The average startup value when the investment from Teva Pharmaceutical Industries is 50-100 millions dollars. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top amount of exits for fund were in 2015. Considering the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2006. Opposing the other organizations, this Teva Pharmaceutical Industries works on 49 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 deals per year.
The current fund was established by Chaim Salomon, Moshe Levin, Yitschak Elstein.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Teva Pharmaceutical Industries, startups are often financed by Biomedical Investments, Auriga Partners, Silicon Valley Bank. The meaningful sponsors for the fund in investment in the same round are Pitango Venture Capital, Israel Healthcare Ventures, Giza Venture Capital. In the next rounds fund is usually obtained by Novartis, Israel Healthcare Ventures, Clal Biotechnology Industries.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Ignyta, BiolineRx, Cocrystal Discovery. The fund has exact preference in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Health Care, Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
Related Funds
| Fund Name | Location |
| Allgeier SE | - |
| Atlas Accelerator | Bellevue, United States, Washington |
| B. Riley Financial | California, United States, Woodland Hills |
| Belltown Ventures | - |
| Catalysta Partners | Georgia, Roswell, United States |
| Discovery Capital | British Columbia, Canada, Vancouver |
| Fusheng Group | - |
| Garmin | Schaffhausen, Schaffhausen, Switzerland |
| GfK | Bayern, Germany, Nuremberg |
| HSMR Advisors | - |
| Jebsen Capital | China, Hong Kong, Hong Kong Island |
| Lundin Foundation | British Columbia, Canada, Vancouver |
| Quanta Computer | T'ai-wan, Taitung County, Taiwan |
| Shenzhen Chenglan Zichan | China, Guangdong, Shenzhen |
| SIRIUS Program | England, London, United Kingdom |
| Spieker Partners | - |
| Suprema | - |
| Tiger Holding | Norway, Oslo |
| United Airlines | Chicago, Illinois, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
TransPharma Medical | $18M | 24 Jul 2006 | Israel, North District, Israel |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
TransPharma Medical | $18M | 24 Jul 2006 | Israel, North District, Israel |
